monomethylpropion has been researched along with Chemical Dependence in 29 studies
monomethylpropion: metabolite of dimethylpropion; structure given in first source
2-methylamino-1-phenylpropan-1-one : An aromatic ketone that is propiophenone in which the hydrogen alpha- to the keto group has been replaced by a methylamino group.
methcathinone : A racemate comprising equal amounts of (R)- and (S)-methcathinone.
Excerpt | Relevance | Reference |
---|---|---|
" This paper describes a case of reiterated coma due to an overdose of methcathinone dissolved in alcohol that was taken with bromazepam." | 3.73 | Methcathinone: a new postindustrial drug. ( Belhadj-Tahar, H; Sadeg, N, 2005) |
"Methylenedioxymethamphetamine (MDMA) and methcathinone (MCAT) are abused psychostimulant drugs that produce adverse effects in human users that include hepatotoxicity and death." | 1.56 | High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone. ( Chen, Y; Hall, FS; Saber, YH; Tran, HTN, 2020) |
"A permanent Parkinsonian syndrome occurs in intravenous abusers of the designer psychostimulant methcathinone (ephedrone)." | 1.43 | Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome. ( Donaghy, M; Ilves, P; Johansen-Berg, H; Juurmaa, J; Menke, RA; Müürsepp, A; Nigul, M; Stagg, CJ; Stepens, A; Taba, P; Tomberg, T; Vila, P, 2016) |
"In ephedrone-induced parkinsonism a prominent mixed hyperkinetic-hypokinetic dysarthria occurs that appears related to marked dystonia and bradykinesia and probably reflects manganese induced toxic and neurodegenerative damage to the globus pallidus internus and substantia nigra." | 1.40 | A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse. ( Bonnet, C; Brožová, H; Janelidze, M; Khatiashvili, I; Megrelishvili, M; Okujava, M; Rusz, J; Růžička, E; Sekhniashvili, M; Tolosa, E, 2014) |
"Patients with ephedrone parkinsonism (EP) show a complex, rapidly progressive, irreversible, and levodopa non-responsive parkinsonian and dystonic syndrome due to manganese intoxication." | 1.40 | Eye movements in ephedrone-induced parkinsonism. ( Bergquist, J; Bonnet, C; Botchorishvili, N; Brožová, H; Fiala, O; Gaymard, B; Hanuška, J; Janelidze, M; Jech, R; Kapianidze, M; Khatiashvili, I; Matoušková, O; Megrelishvili, M; Mikeladze, N; Nikolai, T; Okujava, M; Rivaud-Péchoux, S; Roth, J; Rusz, J; Růžička, E; Serranová, T; Sieger, T, 2014) |
"A new form of presumed manganese poisoning has been reported in drug-addicted persons from Russia, Ukraine, and Estonia who have intravenously injected self-prepared methcathinone hydrochloride (Ephedrone)." | 1.34 | Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. ( de Bie, RM; Gladstone, RM; Ko, JH; Lang, AE; Strafella, AP, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (27.59) | 18.2507 |
2000's | 5 (17.24) | 29.6817 |
2010's | 13 (44.83) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
Authors | Studies |
---|---|
Zeng, N | 1 |
Zheng, H | 1 |
Shi, T | 1 |
Zhang, HB | 1 |
Wang, LX | 1 |
Liang, ZY | 1 |
Sun, B | 1 |
Liao, Y | 1 |
Rao, LL | 1 |
Yang, B | 1 |
Yuan, TF | 1 |
Chen, Y | 1 |
Tran, HTN | 1 |
Saber, YH | 1 |
Hall, FS | 1 |
Kałwa, A | 1 |
Bonano, JS | 1 |
Glennon, RA | 3 |
De Felice, LJ | 1 |
Banks, ML | 3 |
Negus, SS | 3 |
Rusz, J | 2 |
Megrelishvili, M | 2 |
Bonnet, C | 2 |
Okujava, M | 2 |
Brožová, H | 2 |
Khatiashvili, I | 2 |
Sekhniashvili, M | 1 |
Janelidze, M | 2 |
Tolosa, E | 1 |
Růžička, E | 2 |
Koksal, A | 2 |
Keskinkılıc, C | 1 |
Sozmen, MV | 1 |
Dirican, AC | 1 |
Aysal, F | 1 |
Altunkaynak, Y | 1 |
Baybas, S | 2 |
Sieger, T | 1 |
Matoušková, O | 1 |
Nikolai, T | 1 |
Hanuška, J | 1 |
Kapianidze, M | 1 |
Mikeladze, N | 1 |
Botchorishvili, N | 1 |
Serranová, T | 1 |
Fiala, O | 1 |
Roth, J | 1 |
Bergquist, J | 5 |
Jech, R | 1 |
Rivaud-Péchoux, S | 1 |
Gaymard, B | 1 |
Suyama, JA | 1 |
Sakloth, F | 1 |
Kolanos, R | 1 |
Lazenka, MF | 1 |
Asser, A | 2 |
Kõks, S | 1 |
Snellman, A | 1 |
Haaparanta-Solin, M | 1 |
Arponen, E | 1 |
Grönroos, T | 1 |
Nairismägi, J | 1 |
Soomets, U | 1 |
Piip, P | 1 |
Eltermaa, M | 1 |
Sauk, M | 1 |
Lindmäe, H | 1 |
Rinne, JO | 1 |
Taba, P | 5 |
Dukat, M | 1 |
Juurmaa, J | 1 |
Menke, RA | 1 |
Vila, P | 1 |
Müürsepp, A | 1 |
Tomberg, T | 1 |
Ilves, P | 1 |
Nigul, M | 1 |
Johansen-Berg, H | 2 |
Donaghy, M | 2 |
Stagg, CJ | 2 |
Stepens, A | 2 |
Yildirim, EA | 1 |
Eşsizoğlu, A | 1 |
Doğu, B | 1 |
Gökalp, P | 1 |
Sikk, K | 3 |
Haldre, S | 3 |
Nyholm, D | 2 |
Askmark, H | 1 |
Danfors, T | 1 |
Sörensen, J | 1 |
Thurfjell, L | 1 |
Raininko, R | 1 |
Eriksson, R | 1 |
Flink, R | 1 |
Färnstrand, C | 1 |
Aquilonius, SM | 3 |
Platkajis, A | 1 |
Boudrias, MH | 1 |
McGraw, M | 1 |
McGraw, L | 1 |
Paris, M | 1 |
Roose, Ä | 1 |
Petterson, J | 1 |
Eriksson, SL | 1 |
Belhadj-Tahar, H | 1 |
Sadeg, N | 1 |
Zjablov, G | 1 |
Asser, T | 1 |
de Bie, RM | 1 |
Gladstone, RM | 1 |
Strafella, AP | 1 |
Ko, JH | 1 |
Lang, AE | 1 |
Sanotsky, Y | 1 |
Lesyk, R | 1 |
Fedoryshyn, L | 1 |
Komnatska, I | 1 |
Matviyenko, Y | 1 |
Fahn, S | 1 |
Kaminski, BJ | 1 |
Griffiths, RR | 1 |
Gorgaslidze, AG | 1 |
Saĭfullaeva, MA | 1 |
Kuz'mina, MM | 1 |
Golitsina, LS | 1 |
Smetnev, AS | 1 |
Emerson, TS | 1 |
Cisek, JE | 1 |
Rosen, DS | 1 |
Goldstone, MS | 1 |
Schechter, MD | 1 |
O'Dea, PJ | 1 |
Murphy, B | 1 |
Balzer, C | 1 |
Kochetkova, EA | 1 |
Sherstiuk, BV | 1 |
Gel'tser, BI | 1 |
1 review available for monomethylpropion and Chemical Dependence
Article | Year |
---|---|
[Cardiorespiratory disorders in drug addiction].
Topics: Adolescent; Adult; Animals; Asthma; Cocaine-Related Disorders; Heart Diseases; Humans; Lung Diseases | 1998 |
28 other studies available for monomethylpropion and Chemical Dependence
Article | Year |
---|---|
Impaired delay discounting and time sensitivity in methcathinone use disorder.
Topics: Decision Making; Delay Discounting; Humans; Impulsive Behavior; Male; Reward; Substance-Related Diso | 2022 |
High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.
Topics: Ammonia; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Glutamic | 2020 |
Characteristic of neuropsychological deficits in patients diagnosed with manganese encephalopathy due to ephedrone use - case series analysis.
Topics: Adult; Brain Diseases; Cognition Disorders; Female; Humans; Male; Manganese Poisoning; Middle Aged; | 2020 |
Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.
Topics: Animals; Benzodioxoles; Brain; Conditioning, Operant; Data Interpretation, Statistical; Designer Dru | 2014 |
A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse.
Topics: Acoustics; Adult; Analysis of Variance; Antiparkinson Agents; Dysarthria; Dystonia; Humans; Magnetic | 2014 |
Evaluation of cognitive characteristics of patients developing manifestations of parkinsonism secondary to long-term ephedrone use.
Topics: Adult; Cognition Disorders; Humans; Male; Manganese Poisoning; Neuropsychological Tests; Parkinsonia | 2014 |
Eye movements in ephedrone-induced parkinsonism.
Topics: Adult; Basal Ganglia; Brain; Eye Movements; Female; Humans; Male; Manganese; Middle Aged; Parkinsoni | 2014 |
Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.
Topics: Amphetamine; Animals; Behavior, Animal; Designer Drugs; Dopamine; Dopamine Plasma Membrane Transport | 2016 |
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese.
Topics: Animals; Autoradiography; Biomechanical Phenomena; Carbon Radioisotopes; Central Nervous System Stim | 2016 |
Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
Topics: Amphetamine; Animals; Behavior, Animal; Dopamine Plasma Membrane Transport Proteins; Fenfluramine; H | 2017 |
Structure-Activity Relationships of Synthetic Cathinones.
Topics: Adrenergic Uptake Inhibitors; Alkaloids; Amphetamines; Animals; Central Nervous System Stimulants; D | 2017 |
Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome.
Topics: Adult; Atrophy; Brain; Case-Control Studies; Female; Gray Matter; Humans; Magnetic Resonance Imaging | 2016 |
[Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report].
Topics: Adult; Antisocial Personality Disorder; Back Pain; Basal Ganglia Diseases; Conversion Disorder; Diag | 2009 |
Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure.
Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Ma | 2010 |
White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome.
Topics: Adult; Basal Ganglia Diseases; Brain; Data Interpretation, Statistical; Diffusion Magnetic Resonance | 2010 |
Bath salts: not as harmless as they sound.
Topics: Adult; Alkaloids; Central Nervous System Stimulants; Drug and Narcotic Control; Emergencies; Househo | 2012 |
Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-up.
Topics: Adolescent; Adult; Biomarkers; Cohort Studies; Estonia; Female; Follow-Up Studies; Hair; Humans; Mal | 2013 |
Methcathinone: a new postindustrial drug.
Topics: Adult; Amphetamines; Anti-Anxiety Agents; Bromazepam; Central Nervous System Depressants; Central Ne | 2005 |
Irreversible motor impairment in young addicts--ephedrone, manganism or both?
Topics: Adult; Brain; Central Nervous System Stimulants; Disability Evaluation; Disease Progression; Dyskine | 2007 |
Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.
Topics: Adult; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinsonian D | 2007 |
Manganic encephalopathy due to "ephedrone" abuse.
Topics: Adult; Basal Ganglia; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Manganese Poisoning; | 2007 |
Intravenous self-injection of methcathinone in the baboon.
Topics: Animals; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Illicit Drugs; Injections, Int | 1994 |
[Cardiac arrhythmia and myocardial contraction in opium and ephedrone addiction].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Echocardiography; Electrocardiography; Electrocardiography, | 1993 |
Methcathinone: a Russian designer amphetamine infiltrates the rural midwest.
Topics: Adult; Animals; Designer Drugs; Female; Humans; Lethal Dose 50; Male; Mice; Michigan; Poisoning; Pro | 1993 |
Methcathinone.
Topics: Adult; Humans; Michigan; Propiophenones; Substance-Related Disorders | 1993 |
'Cat': methcathinone--a new drug of abuse.
Topics: Humans; Propiophenones; Substance-Related Disorders | 1993 |
Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum.
Topics: Amphetamine; Animals; Discrimination, Psychological; Dopamine; Dopamine Agonists; Dopamine Uptake In | 1997 |
Traffic and illegal production of drugs in rural America.
Topics: Cannabis; Crack Cocaine; Humans; Methamphetamine; Propiophenones; Rural Health; Substance-Related Di | 1997 |